Gull my understanding is sometime in 2013, but there is no definite date and no substitute for doing your own research. One of the variables is the rate of patient recruitment. However I would suggest you take a look at the revenue growth which is not reliant on the US market and take a deeper look. IMO this one is undervalued regardless of FDA approvals.
cheers
Ann: Popular Science Best of Award , page-10
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.02 |
Change
-0.080(2.58%) |
Mkt cap ! $212.9M | |||
| Open | High | Low | Value | Volume |
| $3.09 | $3.11 | $3.00 | $438.3K | 144.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3373 | $3.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.04 | 69 | 1 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| AVH (ASX) Chart |